This study examined the antigenic and genetic diversity of serogroup B Neisseria meningitidis (MenB) recovered from invasive meningococcal disease (IMD) cases in Ontario, Canada, over the period 2001-2010 during which no MenB outbreaks had occurred. MenB was found to be responsible for 39 % of all IMD cases, with the remaining cases caused mainly by serogroups Y (28 %), C (23.5 %) and W135 (8 %). One hundred and ninety-three individual MenB case isolates were collected and characterized. Of the 88 sequence types (STs) identified, 75 were grouped into 14 known clonal complexes (CCs), whilst 13 STs were not assigned to any known CC. Fifty-seven different PorA genotypes and 88 STs defined the diversity of invasive MenB in Ontario, which supported the endemic nature of MenB disease in Ontario. Despite the presence of the hypervirulent ST-41/44 and ST-32 CCs, no single ST was predominant and responsible for a large number of IMD cases. Although the Qué bec outbreak clone of ST-269 was also found in Ontario, the 20 case isolates were genetically diverse: they grouped into seven STs and did not have a predominant PorA genotype. eBURST analysis identified a new CC responsible for 14.5 % of the MenB case isolates. The six most common PorA variable region 2 (VR2) genotypes were found in 67 % of invasive MenB isolates.
INTRODUCTION
Neisseria meningitidis is a strictly human pathogen and is also carried in the nasopharynx of otherwise healthy humans. It is a significant cause of bacterial meningitis and other systemic diseases (Rosenstein et al., 2001) . Of the 12 known serogroups, five (A, B, C, Y and W135) are known to cause most of the invasive disease (Vedros, 1987; Rosenstein et al., 2001) , and all five serogroups have the potential to cause outbreaks under the right circumstances (Mayer et al., 2002; Brooks et al., 2006) . Besides the capsular polysaccharide serogroup antigens, subcapsular proteins, such as the major outer-membrane proteins PorB and PorA, which contain the serotype and serosubtype antigens, respectively, are also useful markers for typing purposes (Frasch et al., 1985) . Although antibody-based assays to detect the serogroup, serotype and serosubtype antigens have been in use for decades, nucleotide sequencing of antigen genes has currently gained wider acceptance for routine epidemiological studies (Feavers et al., 1999; Harrison et al., 2011) .
Invasive meningococcal disease (IMD) occurs globally as an endemic or sporadic disease, and occasionally outbreaks or epidemics occur (Al-Tawfiq et al., 2010) . Analysis of N. meningitidis isolates from sporadic disease or asymptomatic carriers shows that the organism is composed of a highly heterogeneous population of bacteria, whilst isolates recovered from outbreaks or epidemics usually belong to only a limited number of clones, so-called hypervirulent clones or lineages (Caugant, 1998) .
In the past two decades (from the late 1980s to the early 2000s), most IMD cases in Canada were caused by N. meningitidis strains belonging mainly to serogroups B and C (Deeks et Navarro et al., 2007) , and to some extent serogroup Y (Tsang et al., 2002 (Tsang et al., , 2007 . Outbreaks of serogroup C IMD due to the hypervirulent clone ET-15 have been described in different Canadian provinces, including Ontario (Ashton et al., 1991a; Pollard et al., 2001; Tyrrell et al., 2002; Patrick et al., 2003; Tsang et al., 2003 Tsang et al., , 2004 . Since the second wave of serogroup C IMD appeared in several Canadian provinces in [2000] [2001] , all provinces and territories have introduced the meningococcal serogroup C (MenC) conjugate vaccine into their routine immunization schedules for infants and school children (Warshawsky et al., 2009) . In the province of Ontario, monovalent C-conjugated vaccine was introduced in September 2004 as a publicly funded immunization programme for children of 1 year of age, and the programme was expanded in January 2005 also to include students of 12 years of age attending grade 7, as well as high-risk groups of all ages (Ontario Ministry of Health and LongTerm Care -Ontario Vaccines: http://www.health. gov.on.ca/en/public/programs/immunization/docs/schedule. pdf). In September 2009, a quadrivalent meningococcal conjugate vaccine replaced the MenC vaccine for the grade 7 school-based programme.
In the meningococcal conjugate vaccine era, most invasive disease in Canada is caused by N. meningitidis strains of serogroups B and Y. However, there have been very few studies to characterize serogroup B N. meningitidis (MenB) isolates in Canada. Ashton et al. (1991b) described the serotypes and serosubtypes of MenB isolates recovered from 1977 to 1989 associated with IMD in Canada. Ashton & Caugant (2001) reported the panmictic nature of MenB disease isolates during a period of endemic disease in Canada. More recently, we reported the emergence of the clone ST-269 in the province of Québec in 2003 causing outbreaks of MenB disease (Law et al., 2006) .
In this study, we characterized invasive MenB isolates in the province of Ontario and compared them with the characteristics of MenB isolates in the neighbouring province of Québec where outbreaks due to MenB have persisted over the last 8 years . The difference in magnitude of MenB disease in these two provinces may be highlighted in the following statistics. Despite a larger population in Ontario (13.3 million in 2010) than in Québec (7.9 million in 2010), and a longer study period in Ontario (2001 ) than in Québec (2003 , there were fewer MenB case isolates found in Ontario (n5193) than in Québec (n5334) (this study and Zhou et al., 2012) . Therefore, the objectives of the current study were to: (i) document the characteristics of invasive MenB in Ontario for baseline information gathered in anticipation of potential MenB vaccine introduction in the future; (ii) compare and contrast MenB isolates in the two most populous and neighbouring provinces in Canada; and (iii) monitor for potential spread of the emerging clone ST-269 to Ontario as a result of ongoing outbreaks caused by this clone in the neighbouring province of Québec.
METHODS
IMD cases and bacterial isolates. Only laboratory-confirmed IMD cases were included in this study, and when N. meningitidis was recovered from multiple specimen types of a single patient, only one isolate was included in the analysis. The Public Health Ontario Laboratory (PHOL) is the provincial reference laboratory where all N. meningitidis isolates are serogrouped and archived.
Identification, serogrouping and typing of meningococci. N. meningitidis was identified by conventional biochemical tests, and serogrouping was carried out by a bacterial agglutination test with rabbit serogrouping antisera at the PHOL (Riou & Guibourdenche, 1992) . Serotyping and serosubtyping were carried out at the National Microbiology Laboratory by whole-cell ELISA (Abdillahi & Poolman, 1987) Multilocus sequence typing (MLST) was carried out according to the method of Maiden et al. (1998) and isolates were assigned to sequence types (STs) according to the Neisseria MLST website (http://pubmlst. org/neisseria). In MLST, unique sequences of each housekeeping enzyme gene are assigned to different alleles, and, based on the combination of the alleles, STs are assigned. Related STs with identical alleles at four or more loci are grouped together as clonal complexes (CCs). MLST data were also analysed by eBURST (Francisco et al., 2009) to understand the relationship of the STs identified in this study. eBURST analysis was carried out using eBURST version 3, developed and hosted at Imperial College London (http://eburst.mlst.net/v3/instructions/8.asp). STs were grouped together using the most stringent setting of having six of their seven housekeeping gene alleles identical to one another -in other words, all STs within the group were single-locus variants (SLVs) of another ST in the group. This is depicted in the eBURST diagram by lines joining STs that are SLVs of each other (see Fig. 1 ).
Sequencing of porA genes was carried out following the protocol of Sacchi et al. (1998) and Clarke et al. (2003) . The PorA variable region (VR) types were described according to the nomenclature given in the N. meningitidis PorA VR database (http://pubmlst.org/neisseria/ PorA/), and de Filippis et al. (2011) . Ontario, Canada, in 2001 Four hundred and ninety-four laboratory-confirmed IMD cases with a N. meningitidis isolate submitted to the PHOL occurred in the 10-year period with a mean of 49 cases per year. The highest number of cases occurred in 2001 when outbreaks due to serogroup C strains were detected in the province (Pollard et al., 2001; Tsang et al., 2003) . The most common serogroup causing IMD cases was MenB (responsible for 39 % of all cases), followed by serogroups Y (28 %), C (23.5 %) and W135 (8 %). There were also two imported cases of serogroup A related to travel to endemic regions (unpublished observation), as well as two isolates expressing both Y and W135 capsular specificities (Tsang et al., 2008) , two null mutants (Johswich et al., 2012) and one strain that could not be grouped (Table 1) .
RESULTS

IMD in
Of the 193 invasive MenB cases, 132 (68 %) were found to have positive blood cultures (including 12 cases with the Invasive serogroup B N. meningitidis in Ontario, Canada organism found in both blood and cerebrospinal fluid cultures, and one case each positive in brain and skin biopsy tissue cultures), whilst in 57 cases (29.5 %), the organisms were recovered from cerebrospinal fluid specimens only. The remaining four cases gave positive cultures from miscellaneous sites (lung or skin lesions).
Clonal analysis of invasive MenB
All 193 isolates could be typed by MLST, and 88 STs were identified: 154 isolates belonged to 75 STs, which in turn were grouped into 14 CCs. Table 2 shows the distribution of invasive MenB isolates according to their clonal groups. The most common CC identified was ST-41/44 or lineage 3 responsible for 39 % (75/193) of all MenB isolates, followed by ST-269 (10 %), ST-32 (8 %), ST-35 (5 %) and ST-162 (4 %). Of the 193 invasive MenB isolates, 129 (67 %) belonged to these five most common clonal groups. Twenty-five isolates belonged to nine other CCs, and ranged in frequency from one isolate (ST-22) to six isolates (ST-60). The remaining 39 isolates belonged to STs not currently classified into any known CCs according to the N. meningitidis MLST website (http://pubmlst.org/ neisseria). However, among these 39 isolates, 27 belonged to two related STs (ST-336 and ST-5571), with six of their seven housekeeping enzyme gene alleles being identical. (Tsang et al., 2008) .
dOne was a null mutant and the other was ctrA-positive but lacked genes for serogroups A, B, C, Y, W135, X, Z and 29E, and also failed to agglutinate in any of the antiserogrouping antisera.
The remaining 12 isolates were classified into 11 different STs, and, with the exception of one ST that caused two cases, the other ten STs each caused only a single case. Nineteen different serosubtype (PorA) antigen patterns were detected among 156 MenB isolates, whilst in the remaining 37 isolates, no serosubtype antigen was detected (Table 3) . One hundred and twenty-four isolates expressed VR2 epitopes exclusively, detectable by mAbs. In contrast, only 12 isolates expressed VR1 epitopes exclusively, whilst 18 isolates expressed both VR1 and VR2 epitopes, and two isolates expressed the P1.6 epitope thought to be residing on the VR3 region. The three most common VR2 epitopes (P1.4, P1.14 and P1.9) were found to be expressed by 51.3 % of the isolates (n599). The next three most common PorA epitopes were found in only 21 isolates to give a total of 120 isolates or 62.2 % expressing the six most common PorA epitopes.
A total of 57 different PorA genotypes were detected, which included 28 types that occurred only once in single case isolates, 12 genotypes that occurred twice, seven genotypes that occurred three times, two genotypes that occurred four times and two genotypes that occurred five times. Six genotypes occurred six or more times, and they included P1.22, 14, 36 (n536), P1.7-2, 4, 37 (n529), P1.17, 9, 35-1 (n512), P1.22-1, 14, 38 (n511), P1.17, 16-3, 36 (n58) and P1.22, 9, 35-1 (n56) . Together these six genotypes accounted for 102 isolates (53 %). Ontario MenB isolates showed the greatest genetic diversity in their porA VR2 (Ashton et al., 1991b; Kertesz et al., 1998) . The lack of these two serotypes among the invasive MenB isolates was also supported by the absence of the clonal groups of ET-37 or ST-11 and cluster A4 or ST-8 CCs, as these two CCs are often associated with strains possessing the serotype 2a and 2b antigens, respectively (Wang et al., 1993; Caugant, 1998) . (Table 2) , expressing a variety of antigenic profiles (Table S1) , and without a predominating PorA genotype (Table 5) . Although the unique ST-269 strain (B:17:P1.19 with PorA genotype P1.19-1, 15-11, 36) was present in small numbers of case isolates (n53) in Ontario, it did not cause any outbreaks. The reason behind this is not clear. One potential explanation may be the presence of natural immunity in Ontario residents to antigens of this clone, thereby suppressing this clone from spreading and/or causing it to mutate to less virulent forms. Another possibility may be related to the difference in genetic susceptibility of the host found among residents of Québec and Ontario. The dynamics between meningococcal carriage and IMD is a complex interaction between the bacterium and the host. N. meningitidis is considered by some to be a commensal bacterium and only an accidental pathogen under certain conditions or circumstances, which are not clearly defined at this time (Maiden & Urwin, 2006 ).
On the surface, although there were roughly the same number of case isolates and STs involved in the ST-41/44 CC in Ontario (75 isolates and 35 STs) and Québec (78 isolates and 31 STs), it is interesting to note that the actual STs found in these two provinces were quite different. Of the 35 STs found in Ontario, 24 were unique to Ontario and not found in Quebec, whilst in Quebec, 20 of the 31 STs were unique (i.e. not found in Ontario). Of the 55 unique STs found in these two provinces, only 11 STs were common to both provinces. Some of the noticeable differences included: 27 case isolates of ST-571 found in Québec but absent in Ontario; and nine case isolates of ST-6617 and seven case isolates of ST-6169 found in Ontario (this study) but absent in Québec . Also of interest, these three STs have not been found in large numbers in other parts of the world where MenB isolates have been characterized by MLST (Takahashi et al., 2004; Chiou et al., 2006; Yang et al., 2008; Harrison et al., 2010; Lucidarme et al., 2010) .
The ST-41/44 CC has been described as two related groups of STs, with one group clustered around ST-41 and often associated with disease, whilst the other group is clustered around ST-44 and often associated with carriage (Yazdankhah et al., 2004) . eBURST analysis of the Ontario invasive MenB case isolates (Fig. 1) (Joseph et al., 2010) , this study identified a cluster of eight case isolates that involved four ST-136 isolates with another four isolates being SLVs of ST-136 (Fig. 1) . Another group of MenB isolates identified by eBURST analysis was the ST-336 cluster, responsible for 28 (14.5 %) MenB IMD cases, and was the second largest Zhou et al., 2012) .
In England and Wales, with a mean annual IMD incidence of 2.0 per 1 million of the population during the period 2006-2011, ST-269, ST-41/44, ST-213 and ST-32 CCs were identified most frequently, accounting for 35.6, 33.0, 13.2 and 6.5 %, respectively, with the remaining due to other CCs (Ladhani et al., 2012) . In Ontario, the most frequently identified CCs were ST-41/44 (38.9 %), ST-269 (10.4 %), , ST-35 (5.2 %) and ST-162 (4.2 %). The remaining 33 % were due to a large number of STs (n529) grouped into nine other CCs, with 13 STs not grouped into any known CC.
The capsular polysaccharide of MenB contains the self antigen present in neural cells (Finne et al., 1983) . Therefore, development of a universal vaccine against serogroup B based on its capsule is not feasible. Despite this worry that the MenB capsule may induce autoimmunity, MenB disease or the presence of antibodies to the serogroup B capsule has not been reported to be associated with autoimmune disease after decades of observation (Howitz et al., 2007; Robbins et al., 2011) . PorA outer-membrane protein (OMP)-based vesicle vaccines have been developed and used in countries that had experienced epidemics of serogroup B IMD (Bjune et al., 1991; Sierra et al., 1991; de Moraes et al., 1992; Oster et al., 2005) . As the VR2 segment of the meningococcal PorA OMP is the major target for bactericidal activity of immune serum developed towards PorA (Martin et al., 2006) , it is of interest to note that more isolates examined in this study expressed detectable PorA VR2 [136 isolates (70.5 %), including 12 that also co-expressed detectable VR1] than VR1 (24 isolates, 12.4 %) epitopes (Table 3) . However, this might be because the mAb typing kit that we used for serosubtyping actually contained reagents for detection of a higher number of VR2 than VR1 epitopes. Another possibility is that VR2 epitopes were better expressed and/ or more accessible to detection by the antibodies than VR1 epitopes. The six most common PorA VR2 genotypes detected in this study were VR2-9, -4, -14, -16, -13-1 and -16-3, which together were found in almost two-thirds of the Ontario MenB case isolates (n5130, 67.4 %). The majority of the isolates (120, 92 %) with these six PorA VR2 genotypes expressed detectable VR2 epitopes ( (Richmond et al., 2012; Santolaya et al., 2012) . The multicomponent meningococcal serogroup B (4CMenB) vaccine contains fHBP, NadA, NHBA and the PorA antigen P1.4 (Giuliana et al., 2006) , and another investigational MenB vaccine contains bivalent fHBP (Pillai et al., 2005) . Extensive heterogeneity in the genetic sequence of the fHBP gene has been identified, and NadA is not present in all N. meningitidis strains (Bambini et al., 2009; Lucidarme et al., 2009 Lucidarme et al., , 2011 . Therefore, the strain coverage of these newer investigational MenB vaccines is not easily discernible compared with that of the A, C, Y and W135 conjugate vaccines or the PorA-based OMP vesicle vaccines. Of interest, 28 (14.5 %) of the MenB case isolates in Ontario expressed the PorA P1.4 epitope detected by mAb as well as predicted by porA genotyping, and were therefore expected to be covered by the PorA component of the 4CMenB vaccine. Furthermore, we, as well as others, have shown the extensive genomic plasticity of N. meningitidis (Holmes et al., 1999; Marri et al., 2010; Hao et al., 2011) . How this property may impact on the MenB vaccine antigens under vaccination pressure will probably require long-term surveillance studies. Therefore, our laboratory surveillance of IMD in Canada continues to focus on PorA antigens and genotypes, and the population biology of strains, as well as the genetic and antigenic diversity of the multiple investigational vaccine antigens, in order to understand the potential coverage of these newer vaccines on Canadian MenB isolates. The availability of a newer generation of sequencing machines that are faster and more affordable than conventional sequencing has allowed many laboratories to embark on whole-genome sequencing projects. This approach has recently been demonstrated to provide rapid and useful typing information for the molecular epidemiology of N. meningitidis and the potential characterization of newer vaccine antigens (Vogel et al., 2012) .
development of this site has been funded by the Wellcome Trust and European Union. Some of the MLST data have been submitted to this website.
